Cargando…
Antiproliferative Evaluation of Novel 4-Imidazolidinone Derivatives as Anticancer Agent Which Triggers ROS-Dependent Apoptosis in Colorectal Cancer Cell
Colorectal cancer (CRC) is one of the most common causes of cancer-related death worldwide, and more therapies are needed to treat CRC. To discover novel CRC chemotherapeutic molecules, we used a series of previously synthesized novel imidazolidin-4-one derivatives to study their anticancer role in...
Autores principales: | Huang, Jiuhong, Wang, Juanli, Song, Guiting, Hu, Chunsheng, Xu, Zhigang, Chen, Zhongzhu, Xu, Chuan, Yang, Donglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783213/ https://www.ncbi.nlm.nih.gov/pubmed/36557977 http://dx.doi.org/10.3390/molecules27248844 |
Ejemplares similares
-
A Novel Imidazopyridine Derivative Exerts Anticancer Activity by Inducing Mitochondrial Pathway-Mediated Apoptosis
por: Wang, Juanli, et al.
Publicado: (2020) -
Pharmacological Targeting of Bcl-2 Induces Caspase 3-Mediated Cleavage of HDAC6 and Regulates the Autophagy Process in Colorectal Cancer
por: Yang, Donglin, et al.
Publicado: (2023) -
Synthesis of Polycyclic Imidazolidinones via Amine
Redox-Annulation
por: Zhu, Zhengbo, et al.
Publicado: (2017) -
CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling
por: Gao, Lixia, et al.
Publicado: (2020) -
Copper-catalyzed reaction of aziridine for the synthesis of substituted imidazolidine and imidazolidinone
por: Hashimoto, Kota, et al.
Publicado: (2023)